Login
$CHRS
$1.07 +$0.06 (5.94%) Close

$CHRS 3 SEC Filings

Filed On Filing
05 Jun 2024 Form 3: Karachun Rita A, Director

No securities owned

22 Feb 2024 Form 3: Erbez Georgia, Director

No securities owned

20 Jul 2023 Form 3: Ryan Michael Lee, Director

No securities owned

28 Mar 2023 Form 3: Reider Paul, Chief Commercial Officer

Holds 89,504 shares of Common Stock

09 Sep 2022 Form 3: McMichael Bryan J, See Remarks

Holds 15,584 shares of Common Stock

20 May 2022 Form 3: O'Donnell-Tormey Jill, Director

No securities owned

06 May 2022 Form 3: Newton Charles W., Director

No securities owned

06 May 2022 Form 3: Newton Charles W., Director

No securities owned

04 Feb 2022 Form 3: Newcomer Lee Nisley, Director

No securities owned

16 Mar 2021 Form 3: Stilwell McDavid, Chief Financial Officer

Holds 10,000 shares of Common Stock

07 Jan 2021 Form 3: Stolper Mark, Director

Holds 8,800 shares of Common Stock

07 Jan 2021 Form 3: Mendelson Alan C, Director

Holds 1,000 shares of Common Stock

03 Aug 2020 Form 3: Tzoumakas Kimberly Jo, Director

No securities owned

08 Jan 2020 Form 3: V-Sciences Investments Pte Ltd, 10% owner and 3 others

Holds 7,381,116 shares of Common Stock

23 Jan 2019 Form 3: Horton Darlene P, See Remarks
20 Nov 2018 Form 3: Vexler Vladimir, Chief Scientific Officer

Holds 12,300 shares of Common Stock, $0.0001 par value

11 May 2018 Form 3: Nussbaum Samuel R Md, Director

No securities owned

05 Mar 2018 Form 3: Anicetti Vincent R, Chief, Quality & Compliance

Holds 5,150 shares of Common Stock, $0.0001 par value

31 Aug 2017 Form 3: V-Sciences Investments Pte Ltd, 10% owner and 3 others

Holds 6,556,116 shares of Common Stock

29 Oct 2015 Form 3: Fmr Llc, 10% owner

Holds 109,478 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support